These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9868392)

  • 1. [Conservative treatment of bladder cancers with radiotherapy and concurrent chemotherapy: results and perspectives].
    Chauvet B; Davin JL; Alfonsi M; Berger C; Vincent P; Reboul F
    Cancer Radiother; 1998; 2(5):499-504. PubMed ID: 9868392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
    Tester W; Caplan R; Heaney J; Venner P; Whittington R; Byhardt R; True L; Shipley W
    J Clin Oncol; 1996 Jan; 14(1):119-26. PubMed ID: 8558186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer?
    Kuczyk M; Turkeri L; Hammerer P; Ravery V;
    Eur Urol; 2003 Jul; 44(1):57-64. PubMed ID: 12814676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Transurethral Resection plus Systemic Chemotherapy as Definitive Treatment for Muscle Invasive Bladder Cancer in Population Level Data.
    Audenet F; Waingankar N; Ferket BS; Niglio SA; Marqueen KE; Sfakianos JP; Galsky MD
    J Urol; 2018 Nov; 200(5):996-1004. PubMed ID: 29879397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
    Zietman AL; Grocela J; Zehr E; Kaufman DS; Young RH; Althausen AF; Heney NM; Shipley WU
    Urology; 2001 Sep; 58(3):380-5. PubMed ID: 11549485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A
    Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
    BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
    Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution.
    Peyromaure M; Slama J; Beuzeboc P; Ponvert D; Debré B; Zerbib M
    Urology; 2004 Jan; 63(1):73-7. PubMed ID: 14751352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
    Maarouf AM; Khalil S; Salem EA; ElAdl M; Nawar N; Zaiton F
    BJU Int; 2011 May; 107(10):1605-10. PubMed ID: 20825396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.
    Splinter TA; Scher HI; Denis L; Bukowski R; Soloway M; Vogelzang N; Klimberg I; Dalesio O; Herr H
    Prog Clin Biol Res; 1990; 353():219-24. PubMed ID: 2217422
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bladder carcinoma 1: Radical cystectomy, neoadjuvant and adjuvant therapy modalities].
    Lampel A; Thüroff JW
    Urologe A; 1998 Jan; 37(1):93-101. PubMed ID: 9540194
    [No Abstract]   [Full Text] [Related]  

  • 14. Current problems and needs in the treatment of pT1 G3 bladder carcinoma.
    Martínez Portillo FJ; Alken P
    Int Urol Nephrol; 2002; 33(1):29-40. PubMed ID: 12090335
    [No Abstract]   [Full Text] [Related]  

  • 15. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
    deVere White RW; Katz MH; Steinberg GD
    J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
    [No Abstract]   [Full Text] [Related]  

  • 16. Point and counterpoint. Radical cystectomy or multimodality therapy for TCC of the bladder?
    Zietman AL; Shipley WU; Kaufman DS; Esrig D; Lytton B
    Contemp Urol; 1995 Jul; 7(7):23-4, 29, 32, passim. PubMed ID: 10150577
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of two prospective bladder-sparing trimodality approaches for invasive bladder cancer: neoadjuvant chemotherapy and concurrent radio-chemotherapy.
    Zapatero A; Martin De Vidales C; Arellano R; Ibañez Y; Bocardo G; Perez M; Rabadan M; García Vicente F; Cruz Conde JA; Olivier C
    Urology; 2012 Nov; 80(5):1056-62. PubMed ID: 22999456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy.
    Soloway MS; Lopez AE; Patel J; Lu Y
    Cancer; 1994 Apr; 73(7):1926-31. PubMed ID: 8137219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors.
    Scrimger RA; Murtha AD; Parliament MB; Venner PM; Hanson J; Houle G; Chetner M
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):23-30. PubMed ID: 11516847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.